Expert Panel Suggests Covaxin For Children Between 2 To 18 Years
Covaxin, Bharat Biotech's COVID-19 vaccine, was recommended by an expert panel on October 12 for use on children aged two to 18. The company has also received a positive response from the Central Drugs Standard Control Organisation (CDSCO) on its clinical trials. Reportedly, children received the same vaccination as adults in separate trials. However, the company is waiting to get the regulatory approvals to launch it in the market.